tiprankstipranks
Trending News
More News >
Shanghai Chicmax Cosmetics Co., Ltd. Class H (HK:2145)
:2145
Hong Kong Market
Advertisement

Shanghai Chicmax Cosmetics Co., Ltd. Class H (2145) AI Stock Analysis

Compare
0 Followers

Top Page

HK:2145

Shanghai Chicmax Cosmetics Co., Ltd. Class H

(2145)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - 4o)
Rating:74Outperform
Price Target:
HK$114.00
▲(18.20% Upside)
Shanghai Chicmax Cosmetics Co., Ltd. receives a strong overall stock score driven by its robust financial performance and positive technical indicators. The company's high profitability margins and low leverage contribute significantly to its financial stability. While the stock shows bullish momentum, the high P/E ratio suggests potential overvaluation, which slightly tempers the overall score.

Shanghai Chicmax Cosmetics Co., Ltd. Class H (2145) vs. iShares MSCI Hong Kong ETF (EWH)

Shanghai Chicmax Cosmetics Co., Ltd. Class H Business Overview & Revenue Model

Company DescriptionShanghai Chicmax Cosmetic Co., Ltd., a multi-brand cosmetics company, engages in the research, development, manufacture, and sale of skincare, and maternity and childcare products in China. The company offers a range of cosmetics, such as essence creams, lotions, shampoos, facial masks, and other skincare and hair care products under the KANS, One Leaf, Baby Elephant, BIO-G, asnami, KYOCA, newpage, ARMIYO, and TAZU brands. It also engages in supply chain management activities. The company was formerly known as Shanghai Kaka Cosmetic Co., Ltd. and changed its name to Shanghai Chicmax Cosmetic Co., Ltd. in 2020. Shanghai Chicmax Cosmetic Co., Ltd. was founded in 2003 and is based in Shanghai, the People's Republic of China.
How the Company Makes MoneyChicmax generates revenue through multiple key streams including direct sales of its cosmetics and skincare products through retail channels, e-commerce platforms, and partnerships with beauty retailers. The company also benefits from private label services where it manufactures products for other brands, thus diversifying its income sources. Furthermore, strategic collaborations with distributors and influencers in the beauty industry enhance its market reach and brand visibility, driving sales growth. The company's focus on research and development allows for the continuous introduction of new products, keeping its offerings fresh and appealing to a broad consumer base.

Shanghai Chicmax Cosmetics Co., Ltd. Class H Financial Statement Overview

Summary
Shanghai Chicmax Cosmetics Co., Ltd. demonstrates strong financial performance with robust revenue growth, high profitability margins, and low leverage. The company effectively utilizes its equity to generate returns, although there is room to improve cash conversion efficiency. Overall, the financial statements reflect a well-managed company with a positive growth outlook and financial stability.
Income Statement
85
Very Positive
Shanghai Chicmax Cosmetics Co., Ltd. shows strong revenue growth with a TTM increase of 4.27%. The company maintains high gross and net profit margins at 75.22% and 11.50%, respectively, indicating robust profitability. EBIT and EBITDA margins are also healthy, reflecting efficient operations. Overall, the income statement reflects a positive growth trajectory and strong profitability.
Balance Sheet
78
Positive
The balance sheet is solid with a low debt-to-equity ratio of 0.05, indicating low leverage and financial stability. The return on equity is impressive at 36.37%, showcasing effective use of equity to generate profits. The equity ratio stands at 61.41%, suggesting a strong equity base relative to total assets. Overall, the balance sheet reflects financial stability and efficient equity utilization.
Cash Flow
72
Positive
Cash flow analysis shows a significant improvement in free cash flow growth at 20.27% TTM, indicating enhanced cash generation capabilities. The operating cash flow to net income ratio is moderate at 0.16, while the free cash flow to net income ratio is 0.44, suggesting room for improvement in cash conversion efficiency. Overall, the cash flow statement indicates positive cash flow growth but highlights potential areas for enhancing cash efficiency.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue7.40B6.79B4.19B2.68B3.62B3.38B
Gross Profit5.53B5.11B2.99B1.70B2.36B2.19B
EBITDA808.01M752.09M676.04M268.88M404.70M403.95M
Net Income904.16M781.21M461.10M147.10M338.89M203.46M
Balance Sheet
Total Assets3.95B3.60B3.13B3.15B2.27B2.22B
Cash, Cash Equivalents and Short-Term Investments799.88M732.71M914.50M1.17B157.26M174.24M
Total Debt300.83M111.67M165.57M728.20M285.04M544.10M
Total Liabilities1.45B1.36B1.10B1.44B1.32B1.64B
Stockholders Equity2.43B2.19B2.01B1.71B949.98M578.95M
Cash Flow
Free Cash Flow473.06M304.38M657.69M-23.51M269.46M124.56M
Operating Cash Flow715.30M546.95M746.16M36.56M335.19M265.97M
Investing Cash Flow-74.30M-187.03M-457.49M-66.78M-55.29M-6.95M
Financing Cash Flow-556.10M-595.67M-737.21M1.03B-289.56M-239.93M

Shanghai Chicmax Cosmetics Co., Ltd. Class H Technical Analysis

Technical Analysis Sentiment
Positive
Last Price96.45
Price Trends
50DMA
94.88
Positive
100DMA
84.50
Positive
200DMA
65.25
Positive
Market Momentum
MACD
0.75
Negative
RSI
51.34
Neutral
STOCH
71.23
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2145, the sentiment is Positive. The current price of 96.45 is below the 20-day moving average (MA) of 97.24, above the 50-day MA of 94.88, and above the 200-day MA of 65.25, indicating a neutral trend. The MACD of 0.75 indicates Negative momentum. The RSI at 51.34 is Neutral, neither overbought nor oversold. The STOCH value of 71.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2145.

Shanghai Chicmax Cosmetics Co., Ltd. Class H Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
HK$41.39B40.9339.62%2.26%20.78%18.37%
74
Outperform
€3.19B15.006.65%5.48%9.72%-10.15%
72
Outperform
$32.00B12.9610.69%5.54%-3.48%-24.11%
64
Neutral
HK$44.23B17.5829.64%1.57%36.70%22.26%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
47
Neutral
HK$18.88B-6.08%4.58%2.79%-170.67%
41
Neutral
$1.08B-12.38%39.29%-71.82%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2145
Shanghai Chicmax Cosmetics Co., Ltd. Class H
96.45
58.69
155.43%
HK:1044
Hengan International Group Co
27.48
5.19
23.30%
HK:0157
Natural Beauty Bio-Technology
0.54
0.05
10.20%
HK:6601
Cheerwin Group Limited
2.39
0.51
27.13%
HK:2367
Giant Biogene Holding Co. Ltd.
40.40
-9.16
-18.48%
HK:6993
Blue Moon Group Holdings Ltd.
3.06
0.32
11.68%

Shanghai Chicmax Cosmetics Co., Ltd. Class H Corporate Events

Shanghai Chicmax Forms Joint Venture to Expand Cosmetics Market
Apr 17, 2025

Shanghai Chicmax Cosmetics Co., Ltd. has announced the formation of a joint venture with several parties, including Ms. Song Yang and Shanghai Qingdao, with a total registered capital of RMB10,000,000. The company will hold a 51% stake in the venture, which aims to expand its market presence in the cosmetics industry. This transaction is classified as a connected transaction under the Listing Rules, requiring reporting and announcement but exempt from circular and independent shareholders’ approval.

Shanghai Chicmax Announces Final Dividend for 2024
Apr 10, 2025

Shanghai Chicmax Cosmetics Co., Ltd. has announced a final cash dividend of RMB 0.75 per share for the year ended December 31, 2024. This announcement includes details on withholding tax rates applicable to different categories of shareholders, with the payment date set for May 30, 2025. The update reflects changes in information related to withholding tax, impacting non-resident shareholders with varying tax obligations based on their country of domicile and existing tax treaties with the PRC.

Shanghai Chicmax Cosmetics Announces 2025 Annual General Meeting
Apr 10, 2025

Shanghai Chicmax Cosmetics Co., Ltd. has announced its upcoming Annual General Meeting, scheduled for May 6, 2025, in Shanghai. The meeting will address several key resolutions, including the approval of the 2024 work reports, profit distribution plan, auditor appointments, and remuneration plans for directors and supervisors. Additionally, a special resolution will consider amendments to the Articles of Association, highlighting the company’s ongoing efforts to adapt its governance structure. These decisions are crucial for the company’s strategic direction and could impact its operational efficiency and stakeholder relations.

Shanghai Chicmax Reports Strong Financial Growth in 2024
Mar 20, 2025

Shanghai Chicmax Cosmetics Co., Ltd. reported significant financial growth for the year ending December 31, 2024, with a 62.1% increase in revenue and a 74% rise in profit compared to the previous year. The company’s strategic focus on its multi-brand approach, particularly with its KANS brand, has strengthened its market position, with KANS achieving notable success in online sales and product innovation, contributing to the company’s robust performance.

Shanghai Chicmax Expands Product Offerings and Restructures Logistics
Mar 20, 2025

Shanghai Chicmax Cosmetics Co., Ltd. has entered into a Product Purchasing and Services Framework Agreement with Yinxi Shanghai to acquire tea products and teahouse services, marking a strategic move to diversify its product portfolio. Additionally, the company has modified its Logistics and Warehousing Service Agreement, now engaging Hangzhou Rongheng to provide these services, which reflects a restructuring of its logistics operations. These transactions, involving connected parties, are subject to specific reporting requirements under the Listing Rules, but do not require independent shareholder approval, indicating a streamlined regulatory process.

Shanghai Chicmax Announces Final Dividend for 2024
Mar 20, 2025

Shanghai Chicmax Cosmetics Co., Ltd. has announced a final cash dividend of RMB 0.75 per share for the financial year ending December 31, 2024. The dividend is subject to shareholder approval on May 6, 2025, with payment scheduled for May 30, 2025. This announcement reflects the company’s commitment to returning value to its shareholders and may influence its market positioning positively.

Shanghai Chicmax Schedules Board Meeting to Discuss Annual Results and Dividend
Mar 10, 2025

Shanghai Chicmax Cosmetics Co., Ltd. has announced a board meeting scheduled for March 20, 2025, to discuss and approve the company’s annual results for the year ending December 31, 2024. The meeting will also consider the recommendation for a final dividend payment, highlighting the company’s ongoing financial strategies and potential returns for stakeholders.

Shanghai Chicmax Projects Strong Financial Growth for 2024
Mar 3, 2025

Shanghai Chicmax Cosmetics Co., Ltd. has announced a positive profit alert, expecting significant revenue and profit increases for the year ended December 31, 2024. The company anticipates revenue between RMB6,700.0 million and RMB6,900.0 million, and profit between RMB750.0 million and RMB810.0 million, driven by strong performance from its skincare brands KANS and newpage.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 16, 2025